The interleukin-1 pathway as a treatment target in early-stage hidradenitis suppurativa?

Br J Dermatol. 2023 Sep 15;189(4):365-366. doi: 10.1093/bjd/ljad225.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Hidradenitis Suppurativa* / drug therapy
  • Humans
  • Inflammasomes
  • Inflammation
  • Interleukin-1
  • NLR Family, Pyrin Domain-Containing 3 Protein

Substances

  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Interleukin-1